Anti-CCoV Drug Discovery Products
Canine Coronavirus (CCoV) is a viral entity that affects canines. CCoV is a member of the Coronaviridae family, which includes a diverse group of enveloped viruses with positive-sense RNA genomes. Within the family, CCoV falls under the genus Alphacoronavirus, sharing this classification with other canine coronaviruses like the Canine Respiratory Coronavirus (CRCoV). Unlike its infamous human counterpart, CCoV primarily infects domestic dogs, causing enteric disease. Susceptible groups include puppies and dogs with weakened immune systems. Cross-species transmission is not uncommon, with potential spillover from other mammals. The virus mainly targets the intestinal tract, leading to symptoms such as diarrhea and vomiting. Transmission occurs through the fecal-oral route, and although the infection is usually self-limiting, supportive care is essential for affected animals. The virus's genome is comprised of single-stranded RNA, encoding structural and non-structural proteins crucial for its survival and replication. While Canine Coronavirus may not be as widely known as its human counterparts, its discovery, distribution, and genomic analysis contribute to our broader understanding of coronaviruses, fostering awareness and research in the realm of veterinary health. Explore our range of virus antibody products to advance your research in CCoV.
ViroAb™ Mouse Anti-Canine Coronavirus N Monoclonal Antibody (XX0408)